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In the previous studies, the DNA with the bulky Fap-dC derivative was demonstrated to be a 
difficult substrate for the nucleotide excision repair (NER), a system which is involved in the 
removal of bulky lesions from DNA. This type of compounds could be of particular interest 
as possible selective NER, considerably reducing the potency of DNA repair due to competi-
tive immobilization of protein factors involved in this process. This approach can be poten-
tially useful to increase the  efficiency of chemotherapy. Aim. To identify DNA structures 
containing multiple bulky adducts that can efficiently inhibit the nucleotide excision repair. 
Methods. Enzymatic DNA synthesis, PCR, NER-competent cell extract preparation, in vitro 
NER assay, HPLC. Results. The conditions for the synthesis of extended DNA containing 
multiple unrepairable lesions were established. A wide range of DNA structures containing 
modified nucleotides was obtained. All modified DNAs were shown to inhibit the in vitro 
activity of the NER system. The DNA structure that inhibits the NER activity with the highest 
efficiency was selected. Conclusions. The model DNA structures effectively inhibiting the 
activity of NER were found. The new data obtained here can potentially be used for both 
basic and applied research.
K e y w o r d s: DNA repair, nucleotide excision repair, unrepairable DNA lesions, model DNA 
substrates
Introduction
The nucleotide excision repair system (NER) 
removes from the DNA a wide range of bulky 
adducts that are induced into DNA by ultra-
violet light (UV), various chemically active 
compounds (drugs, mutagenic environmental 
compounds), active forms of oxygen and ion-
izing radiation [1]. The damages removed by 
the NER system include the products of pho-
tocrosslinking of adjacent pyrimidine bases, 
platinum adducts, protein-DNA crosslinking; 
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adducts arising from the interaction of active 
derivatives of benzo[a]pyrene, benzo[c]anthra-
cene, acetylaminofluorene with DNA, as well 
as with other bulky adducts, significantly dis-
turbing the regular structure of double-stran ded 
DNA [2].
About 30 proteins are involved in the NER 
process, forming functional complexes at each 
stage of the reparative process [1, 3]. These 
proteins carry out the search for damage, its 
verification and subsequent removal of short 
oligonucleotide containing the lesion. The re-
synthesis of the nucleotide sequence is per-
formed by the specialized DNA repair poly-
merases and several proteins of the DNA rep-
lication.
One of the approaches to the study of NER 
mechanism includes the use of the synthetic 
substrate analogues — double-stranded DNAs 
containing bulky modification in the defined 
position of a molecule, as well as structural 
analogs of the intermediates of NER process 
[4–9]. The model DNAs mimicking various 
NER intermediates can be used as a tool for 
determining the parameters of protein affinity 
to damaged DNA [10, 11]. The extended linear 
DNA duplexes can be also used to study the 
stage of damage elimination and the changes 
of protein-DNA complexes that occur in the 
NER process. Thus, the substrates with bulky 
groups, which are highly recognized and re-
moved from the DNA by the NER system, can 
serve as a tool for determining the activity of 
this system in vitro [12].
The model DNAs containing photoactivat-
able or chemically active groups are of great 
interest, as it can be regarded as the probes 
for affinity modification of proteins [13]. 
Various DNA derivatives containing arylazido 
groups have been used most widely to design 
photoactivatable DNA probes. Their rapid 
activation by exposure to UV light after the 
formation of a complex of photoreactive sub-
strate with the protein makes it possible to 
study the dynamics of the process of protein-
DNA interactions in NER [14]. For instance 
new details of the mechanism of primary dam-
age recognition during the NER process were 
estimated using photoactivatable analogs of 
the NER substrates. The method of photoaf-
finity modification was used to determine a 
character of protein-DNA interactions for the 
main proteins involved in the recognition and 
verification of the damage - XPC, RPA and 
XPA [10, 15–17].
Among the previously used photoactivable 
model DNAs, the 4-azido-2,5-difluoro-3-chlo-
ropyridin-6-yl derivative of dC (Fap-dC) is of 
particular interest. It was shown that Fap-dC 
in the DNA duplex with a length of 137 bp is 
a practically unrepairable damage for the NER 
system [18]. At the same time, DNA containing 
Fap-dC can efficiently bind [the] NER factors 
[19, 20]. Fap-dC demonstrated a high effi-
ciency as a probe for [the] photoaffinity modi-
fication of DNA binding proteins in [the] NER-
competent HeLa cell extracts [11, 18]. Thus, 
DNA of various lengths and structures contain-
ing Fap-dC residue at the defined position was 
successfully used to study the NER system.
The extended model DNA structures con-
taining reactive and hardly repairable damage 
can serve as a useful tool for comparative as-
sessments of the ability to suppress NER, as 
well as for investigations which include visu-
alization of nucleoprotein complexes. The pur-
pose of this work was to obtain extended 
model DNAs containing multiple Fap-dC 
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groups, and to analyze the possible use of such 
DNAs to suppress the activity of the NER 
system.
Materials and Methods
T4-polynucleotide kinase, T4-DNA ligase and 
Taq DNA polymerase were from “Biosan” 
(Novosibirsk); DNA polymerase β was kindly 
provided by S. N. Khodyreva; the set of the 
enzymes for DNA digestion “DNA Degradase” 
was produced by “ZymoResearch”; ɑ-[³²P]-
dCTP and ɣ-[³²P]-ATP (3000 Ci/mmol) were 
produced at ICBFM SB RAS; Fap-dCTP 
(Fig. 1A) was synthesized as described in [21] 
and kindly provided by I. V. Safronov; oligo-
deoxyribonucleotide containing non-nucleo-
side insertion nAnt (ONT-1, Table 1; Fig. 1B) 
was synthesized as described in [12]; C33A 
(human cervical cancer cell line) cells were 
kindly provided by N. P. and F L. Kisselev. 
Furthermore, proteinase K, dNTP’s (“Biosan”, 
Novosibirsk), urea, N,N’-methylenbi sacrila-
mide (“Amersco”), acrilamide (“Applichem”), 
TEMED (“Helicon”), DEAE filters DE-81 
(“Whatman”), DNA Gel Extraction Kit 
QIAquick (“Qiagen”), Quick Start Bradford 
Protein Assay Kit (“Biorad”) were used in this 
work.
The sequences of the oligodeoxyribonucle-
otides (ONT) used are shown in Table 1.
Synthesis of 137-nt DNA duplex containing 
non-nucleoside insertion nAnt. ONT-1 contain-
ing non-nucleoside fragment with N-[6-(9-
Table 1. The numbering, sequence and length of oligonucleotides (ONT) used.
ONT # Sequence length, nt
1 5’-caccgtcMccctggat* 16
2 5’-caccgtcgccctggat 16
3 5’-tggacgatatcccgcaagaggcccggcagtaccggcataaccaagcctatgcctacagcatccaggg 67
4 5’-gacggtgccgaggatgacgatgagcgcattgttagatttcatacacggtgcctgactgcgttagcaatt 69
5 5’-gcctacagcatccagggcgacggtgccgaggatg 34
6 5’-atcaccggcgccaca 15
7 5’-gtatccgctcatgagacaat 20
8 5’-gggggctcggcaccgtcaccctggatgctgtagg 34
*M – non-nucleoside insertion nAnt.
Fig. 1. Structures of model lesion used. Exo-N-{2-[N-(4-
azido-2,5-difluoro-3-chloropyridin-6-yl)-3-aminopropio-
nyl]aminoethyl}-deoxycytidinine (Fap-dC, A) and the non-
nucleoside fragment of the modified DNA strand, contain-
ing N-[6-(9-antracenylcarbomoyl)hexanoyl]-3-amino-1,2-
propandiol (nAnt, B)].
A
B
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antracenylcarbomoyl)hexanoyl]-3-amino-1,2-
propandiol (nAnt), flanking 5’-[³²P]-ОNТ-3 
and ОNТ-4 were mixed with template ОNТ-5 
in equimolar amount. The mixture was heated 
at 95ºС for 5 min, than slowly cooled (about 
of 1ºС per minute) to the room temperature. 
The ligation of the single strand breaks was 
carried out by the addition of Т4 DNA ligase 
and ATP with the following incubation at 12°С 
for 12 h. Single-stranded DNA obtained was 
purified by electrophoresis in polyacrylamide 
gel under denaturing conditions according to 
[22]. Briefly, the target DNA was separated by 
electrophoresis and was isolated from gel by 
electroelution to DEAE filter. The elution of 
oligonucleotide from DEAE filter was per-
formed at 70ºС by 3 М LiClO4. DNA was 
precipitated with acetone and dissolved in TE 
buffer. The resulting modified DNA was an-
nealed with the appropriate complementary 
strand.
Synthesis of 756-nt DNA by PCR. Non-
modified 756 bp DNA was obtained by PCR 
using pBR322 as template and ОNT-6 and 
ОNТ-7 as primers. The 100 μl of reaction 
mixture contained 25 ng of a template, 0.5 µМ 
primers, 0.2 mМ dNTP’s, 1.5 mM MgCl2 and 
6 units of Taq DNA polymerase in Taq DNA 
polymerase reaction buffer. In order to obtain 
the modified DNA of the same length, PCR 
was carried out under the same conditions with 
addition of 5 to 160 µМ Fap-dCTP in the reac-
tion mixture. PCR products were precipitated 
with ethanol in 0.3 M CH3COONa (pH 5.5) 
with linear polyacrylamide as a co-precipitant 
and then dissolved in TE buffer. Purification 
of PCR products was carried out by electro-
phoresis in 1 % agarose gel. Isolation of DNA 
from agarose gel was performed using 
QIAquick Kit (“Qiagen”) according to proto-
col provided by manufacturer.
Resulting DNAs concentrations were deter-
mined by measuring the optical density of the 
solution at 260 nM. The concentration of DNA 
obtained was calculated using “OligoCalculator”.
NER-competent C33A cell extract was ob-
tained by the standard method described in 
[23]. The concentration of protein in the ex-
tract was determined using Quick Start 
Bradford Protein Assay Kit (“Bio Rad”), using 
BSA as a standard for the calibration curve.
Analysis of relative NER efficiency was car-
ried out by the method described in [12] using 
137 bp DNA containing nAnt lesion, and 
ОNТ-8 as a template for detection of the exci-
sion products. Briefly, the excision products 
were detected by annealing to the template 
followed by end-labeling using α-[32P]-dCTP 
and Taq DNA polymerase. The analysis of the 
excision products was performed by electro-
phoresis in 10 % polyacrilamide under dena-
turating conditions. Mixture of [³²P]-5ꞌ-labeled 
oligodeoxyribonucleotides was used as a DNA 
ladder. To estimate the influence of 756 bp 
Fap-dC- and non-modified DNA on specific 
excision of nAnt lesion from the model DNA 
the extended DNA was added into reaction 
mixtures during the excision reaction.
Enzymatic hydrolysis of 756-strand DNA to 
deoxymononucleotides was performed using 
the DNA Degradase kit (“Zymo Researsh”) 
according to the manufacturer’s protocol.
Analysis of a mixture of mononucleotides 
was performed using high performance liquid 
chromatography (HPLC) with chromatograph 
Milichrom A-02 and ProntoSIL-120-5-C18 AQ 
column. Gradient from 0 % acetonitrile in 0.05 
triethylamine acetate (TEEAAc) to 100 % 
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acetonitrile in 0.05 TEEAAc was used at pH 
7.5, 40°С, 0.15 ml/min and 3.9 MPa.
Results and Discussion
Synthesis of 756 bp DNA duplexes was per-
formed using PCR. To ensure the specificity 
and productivity of the synthesis of the target 
product, the conditions for PCR were opti-
mized: the time of each stage of the cycle was 
determined, the optimal composition of the 
buffer, the concentration of dNTP and primers 
were selected.
A modified analogue of nitrogenous bases - 
exo-N-{2-[N-(4-azido-2,5-difluoro-3-chloro-
pyridin-6-yl)-3-aminopropionyl]aminoethyl}-
deoxycytidinine (Fap-dC, Fig. 1A) was used 
as one as the model lesion. Extended (756 bp) 
Fap-dC-DNAs were obtained by adding the 
Fap-dCTP (up to 5, 10, 20, 40, 80, and 160 μM) 
to the reaction mixture during PCR (Table 2).
In addition to the 756 bp Fap-dC-DNA 
containing different number of modified nu-
cleotides and non-modified DNA of the same 
length and sequence, 137 bp nAnt-DNA 
(Fig 1B) was obtained.
Table 2. DNA obtained using the PCR and 
modified triphosphate.
DNA formal name The concentration of Fap-dCTP in the 
reaction mixture during PCR, μM
nm DNA 0
5-Fap-dC-DNA 5
10-Fap-dC-DNA 10
20-Fap-dC-DNA 20
40-Fap-dC-DNA 40
80-Fap-dC-DNA 80
160-Fap-dC-DNA 160
It was previously shown that nAnt is ef-
fectively removed by proteins of the NER 
system from model DNA in vitro [12, 19]. The 
properties of nAnt-DNA as a NER substrate 
allow us to use it in our study for estimation 
of NER activity in vitro.
To assess the ability of model DNAs to 
suppress the activity of the NER system, the 
influence of such DNA on NER efficiency in 
vitro was studied. The efficiency of excision 
was estimated using extracts of human cervical 
cancer cells C33A. The incubation of 20 nM 
137 bp nAnt-DNA with cell extracts was car-
ried out in [the] presence or absence of 3 nM 
756 bp competitive DNA. Non-modified DNA 
(nm DNA) or DNA containing the Fap-dC 
groups was used as a competitive DNA. The 
products of the specific excision obtained dur-
ing the reaction were analyzed in 10 % PAAG 
under denaturing conditions.
It was found that Fap-dC-containing DNA 
effectively suppresses the excision of bulky 
lesion from nAnt-containing DNA. The ob-
served decrease in the relative efficiency of 
nAnt excision was 50–80 %, depending on the 
concentration of Fap-dCTP used in the synthe-
sis of Fap-dC-DNA (Fig. 2). The greatest effect 
was observed in the experiment, where 40-Fap-
dC-DNA was used as a competitor (Fig. 2A, 
line 6). Thus, this DNA structure can be con-
sidered as DNA with unrepairable damage, 
which most effectively inhibits the activity of 
the NER system.
To estimate the number of modified nucle-
otides included in 756 bp DNA during PCR, 
40-Fap-dC-DNA was enzymatically hydro-
lyzed using “DNA Degradase” kit.
The resulting mixture of mononucleotides 
was analyzed by high performance liquid chro-
matography (HPLC) with chromatograph 
Milichrom A-02 and ProntoSIL-120-5-C18 AQ 
column. Modified Fap-dC nucleotide has sig-
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nificantly higher retention time in the condi-
tions used, so it was possible to calculate the 
corresponding peak area precisely. The peak 
areas corresponding to unmodified nucleotides 
were also calculated. Taking into account the 
values of extinction of nucleotides at the used 
wavelength, the amount of the modified nu-
cleotide in the resulting mixture was estimated. 
It was found that hydrolyzate, and, conse-
quently, the 40-Fap-dC-DNA contains approx-
imately one modification per 20 non-modified 
nucleotides. The ratio of the modified to non-
modified triphosphates in the reaction mixture 
during PCR was also 1:20. Thus we can con-
clude that the modified dC is incorporated into 
the DNA during DNA synthesis catalyzed with 
Taq DNA polymerase with high efficiency 
matching the efficiency of unmodified dCTP 
incorporation. The results are consistent with 
the data obtained in the study of the substrate 
properties of Fap-dCTP in another incorpora-
tion reaction – the reaction catalyzed by DNA 
polymerase β [21].
For the ability of model DNA to bind repair 
factors, not only the DNA sequence is crucial 
[24], but also the spatial organization of the 
DNA fragment in the damaged region [25–27].
According to our previous studies, Fap-dC 
lesion incorporated into DNA significantly 
affects the double-stranded structure of DNA. 
The long and flexible linker enables intercala-
tion of the fluoroazido-pyridyl ring into the 
DNA helix. It results in stacking this residue 
with the purine rings of the opposite dG, and 
no destabilization of the regular DNA duplex 
structure was found at the damaged site. The 
destabilized helical element is located on the 
3′ side of the lesion [19]. Considering the 
Fig. 2. A — NER dual incision activity of C33A cell extract on nAnt-DNA, detected after 40 min incubation of model 
DNAs with cell extract. Reaction mixtures containing 20 nM nAnt-DNA were incubated with C33A cells extract for 
40 min at 30°C in the absence (lane 1) or presence of 3 nM competitive DNA (lane 2 – non-modified duplex, lane 3 – 
5-Fap-dC-DNA, lane 4 – 10-Fap-dC-DNA, lane 5 – 20-Fap-dC-DNA, lane 6 – 40-Fap-dC-DNA, lane 7 – 80-Fap-dC-
DNA, lane 8 – 160-Fap-dC-DNA). M – markers of DNA length (nt, nucleotide), the lengths of the marker DNAs are 
given on the right. B — The dependence of relative efficiency of the NER on the type of competitive DNA. Maximum 
product accumulation was taken as unit and was detected for nAnt-DNA incubated with cell extract for 40 min. Each 
experiment was performed three times, error bars indicate standard deviation of the relative NER efficiency at each 
experimental point.
A B
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previously obtained data and the calculated 
number of the modified groups into model 
DNA, we can assume the possible location of 
Fap-dC and the destabilization caused by le-
sions in Fap-dC-DNA. We assume that the 
ratio of modified to non-modified nucleotides 
into 756 bp DNA under 1:20 allows the forma-
tion of several separate sites of DNA structure 
destabilization (Fig 3A). Such destabilization 
sites can be recognized by repair factors, such 
as XPC-HR23B, increasing their affinity for 
this type of structure. Being bound in unpro-
ductive complexes with Fap-dC-DNA, repair 
proteins can no longer participate in reparative 
processes. The copy number of NER proteins 
in the cell, and hence in cell extracts, is rela-
tively small [28, 29]. Therefore, even a small 
amount of the extended DNA is sufficient to 
significantly suppress the activity of NER.
An increase in the ratio of modified to non-
modified nucleotides in the DNA composition 
up to 1:20 leads to the appearance of the ad-
ditional binding sites for repair factors, and 
hence to a more pronounced suppression of 
the NER activity. But a further increase in the 
number of modified groups leads to the inter-
ference of areas of the regular double-stranded 
structure destabilization (Fig. 3B). The ques-
tion of the spatial organization of such DNA 
needs additional research. However, it can be 
assumed that significant distortions of the ge-
ometry and structure of the DNA duplex in this 
case interfere with their recognition as a NER 
substrate, and prevent the binding of repair 
factors with such model DNA.
The model DNAs with unrepairable lesions 
that can inhibit NER with high efficiency are 
of considerable interest. It is known that the 
main drugs used in the treatment of malignant 
tumors are cytostatics. Such drugs are able to 
disrupt the structure of the DNA in the cell, 
which leads to the activation of damage repair 
A
B
Fig. 3. Estimated patterns of duplex 
structure destabilization in Fap-dC-
DNA. The low ratio of modified to 
non-modified nucleotides presumably 
leads to the formation of separate re-
gions of duplex structure destabiliza-
tion (blue rectangles), while high ratio 
- to the formation of interfered regions 
(red rectangles). The most probable 
hydrogen bonds are also indicated: 
bold lines represent the hydrogen 
bonds occurring with more than 90 % 
probability, thin lines – 50–90 %, 
dashed line – 10–50 %.
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systems. In case of adequate regimens of treat-
ment and suitable cytostatic agent selection, 
the tumor cells are eliminated as a result of the 
induction of irreversible apoptosis or another 
mechanism of elimination. In this regard, the 
basis of successful treatment is the therapeutic 
“competence” of the drug used and the number 
of cytostatic molecules in the cell (the drug 
dose). However the activity of the NER system 
can eliminate the damage and reduce the ther-
apeutic effect of anticancer drugs [30, 31]. The 
cytostatics with different mechanisms of action 
are used in the world practice. These are drugs 
that disrupt the DNA structure, and drugs that 
induce intrastrand or interstrand crosslinks. In 
all cases, if any of these lesions occur, a nu-
cleotide excision repair system is induced as 
one of the earliest cell defense systems [32, 
33]. If the damages have [been] detected and 
the repair process has occurred, the amount of 
damage per cell could decrease to [the] under-
therapeutic levels. A cancer cell has significant 
genetic plasticity [34]. They are quite often 
highly resistant for cytostatic actions and sur-
vive, increasing the chance of relapse. 
Therefore, the DNA structures capable of ef-
fective inhibition of the activity of the NER 
system can be considered as potential anti-
cancer drugs. The model DNA with bulky 
unrepairable adducts could inhibit the repair 
process by binding the key protein factors of 
the NER system. In this regard, the presence 
of model DNA with unreparable damage 
should increase the cytotoxicity of anticancer 
therapy based on the cytostatic agents, induc-
ing inter- and intrastrand crosslinks into cell 
DNA, as well as the bulky lesions formation. 
Thus, the results of our investigation can po-
tentially be used for design of DNA repair 
inhibitors and potentially in the applied re-
search.
Conclusions
In the present report a new approach to the 
synthesis of DNA with unrepairable lesions 
was described. The obtained DNA structures 
were shown to inhibit the nucleotide excision 
repair in vitro. The DNA structure that inhibits 
the NER with the highest efficiency was se-
lected for the further study and analyzed. The 
suggestion concerning the possible connection 
between the number of the modified nucleo-
tides introduced in the model DNAs and their 
ability to inhibit the NER process was made. 
The data obtained in this paper will be useful 
for fundamental and medical research.
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Нерепаровані аналоги субстатті ексцизійної 
репарації нуклеотидів і їх застосування для 
придушення активності цієї системи
О. О. Попов, А. М. Євдокимов, 
Н. В. Лук'янчикова, І. О. Петрусева, О. І. Лаврик
У наших попередніх дослідженнях було показано, що 
ДНК з об'ємним похідним Fap-dC є складнорепарова-
ним субстратом для системи ексцизійної репарації 
нуклеотидів (Ерн). З'єднання такого типу можуть ста-
новити особливий інтерес як можливі селективні ін-
гібітори системи Ерн, значно знижуючи ефективність 
репарації ДНК шляхом зв'язування білкових чинників, 
залучених до даного процесу. Цей підхід може бути 
потенційно корисний для підвищення ефективності 
хіміотерапії. Мета. Дане дослідження спрямоване на 
пошук ДНК-структур, що містять множинні об'ємні 
аддукти, які з найбільшою ефективністю можуть при-
гнічувати активність системи. Методи. Фермен та тив-
ний синтез ДНК, ПЛР, приготування Ерн-компетентних 
клітинних екстрактів, реакція вирізання, що каталізу-
ється білками Ерн in vitro, ВЕРХ. Результати. 
Проведено підбір умов синтезу протяжних модельних 
ДНК з множинним включенням нерепарованого по-
шкодження Fap-dC. Отримано ряд ДНК-структур, що 
містить в своєму складі різну кількість модифікованих 
ланок. Показано, що всі отримані ДНК пригнічують 
активність системи Ерн in vitro. Обрана ДНК-
структура, яка пригнічує NER найбільш високою ефек-
тивністю. Висновки. Модельні ДНК з нерепаровани-
ми ушкодженнями, здатні високою ефективністю при-
гнічувати NER, можуть розглядатися в якості інгібіто-
рів системи Ерн. Виявлені в даній роботі закономір-
ності потенційно можуть бути використані для 
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проведення як фундаментальних, так і прикладних 
досліджень.
К л юч ов і  с л ов а: репарація, Ексцизійна репарація 
нуклеотидів, нерепаріруемие пошкодження ДНК, мо-
дельні ДНК-субстрати
Нерепарируемые аналоги субстатов 
эксцизионной репарации нуклеотидов и их 
применение для подавления активности этой 
системы
А. А. Попов, А. Н. Евдокимов, Н. В. Лукьянчикова, 
И. О. Петрусева, О. И. Лаврик
В наших предыдущих исследованиях было показано, 
что ДНК с объемным производным Fap-dC является 
труднорепарируемым субстратом для системы эксци-
зионной репарации нуклеотидов (ЭРН). Соединения 
такого типа могут представлять особый интерес как 
возможные селективные ингибиторы системы ЭРН, 
значительно снижая эффективность репарации ДНК 
путем связывания белковых факторов, вовлеченных в 
этот процесс. Этот подход может быть потенциально 
полезен для повышения эффективности химиотерапии. 
Цель. Текущее исследование направлено на поиск 
ДНК-структур, содержащих множественные объемные 
аддукты, которые с наибольшей эффективностью мо-
гут подавлять активность системы. Методы: фермен-
тативный синтез ДНК, ПЦР, приготовление ЭРН-
компетентных клеточных экстрактов, реакция выреза-
ния, катализируемая белками ЭРН in vitro, ВЭЖХ. 
Результаты: был проведен подбор условий синтеза 
протяженных модельных ДНК с множественным вклю-
чением нерепарируемого повреждения Fap-dC. 
Получен ряд ДНК-структур, содержащий в своем 
составе различное количество модифицированных 
звеньев. Было показано, что все полученные ДНК 
подавляют активность системы ЭРН in vitro. Была 
выбрана ДНК-структура, которая ингибирует NER 
наиболее высокой эффективностью. Выводы: модель-
ные ДНК с нерепарируемыми повреждениями, спо-
собные высокой эффективностью подавлять NER, 
могут рассматриваться в качестве ингибиторов систе-
мы ЭРН. Обнаруженные в настоящей работе законо-
мерности потенциально могут быть использованы для 
проведения не только фундаментальных, но и приклад-
ных исследований.
К л юч е в ы е  с л ов а: эксцезионная репарация ну-
клеотидов, нерепарируемые повреждения ДНК, мо-
дельные ДНК-субстраты.
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